Abstract The 2018 Nobel Prize in Physiology or Medicine was awarded to pioneers in the
field of cancer immunotherapy, as the utility of leveraging a patient's coordinated and …

Although cancer immunotherapy can lead to durable outcomes, the percentage of patients
who respond to this disruptive approach remains modest to date. Encouragingly …

Cancer immunotherapy utilizes the immune system to fight cancer and has already moved
from the laboratory to clinical application. However, and despite excellent therapeutic …

Cancer immunotherapy is an emerging treatment strategy that modulates the immune
system to fight against cancer. Although several immunotherapeutic agents have been …

Immunotherapy is emerging as a groundbreaking cancer treatment, offering the
unprecedented opportunity to effectively treat and in several cases, even cure previously …

Two major obstacles facing cancer nanomedicine are the tendency of nanoparticles to be
taken up by normal tissues and organs and the nanoparticles' inability to efficiently penetrate …

Immunotherapy is known to be clinically beneficial for cancer patients and in many cases
represents the new standard of care. Because of this success, the interest in integrating …

Immunotherapy has become a powerful clinical strategy for treating cancer. The number of
immunotherapy drug approvals has been increasing, with numerous treatments in clinical …

Therapeutic targeting of the immune system in cancer is now a clinical reality and marked
successes have been achieved, most notably through the use of checkpoint blockade …

Cancer immunotherapy is now a powerful clinical reality, with a steady progression of new
drug approvals and a massive pipeline of additional treatments in clinical and preclinical …